Skip to main content
. 2017 Sep 21;7:12045. doi: 10.1038/s41598-017-11533-1

Figure 4.

Figure 4

(A) Schematic overview of the module-based microfluidic system. Liposomes were manufactured with a Staggered Herringbone Mixer (SHM) upstream and flowed through the Tangential Flow Filtration (TFF) device for consecutive purification. (B) Schematic overview of the formation of liposomes loaded with a low-solubility model drug, i.e. propofol. Vesicle assembly and drug loading are performed with a SHM, and non-entrapped (free) drug is removed from the mixture by consecutive filtration inside the TFF system. (C) Schematic overview of the formation of liposomes loaded with a model protein, ovalbumin (OVA). Vesicle assembly is performed with a SHM, with post-assembly protein addition; non-entrapped (free) protein is removed by consecutive diafiltration cycles inside the TFF system.